Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: GlobeNewswire
Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year Company well positioned to invest in membership growth and Clover Assistant technology, while maintaining strong profitability Issues full year 2025 guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpointInsurance revenue between $1.800 billion and $1.875 billion, representing 37% growth year-over-year at the midpointAdjusted EBITDA profitability between $45 million and $70 millionAdjusted Net income between $45 million and $70 million WILMINGTON, Del., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the fourth quarter and full year 2024. Management will host a conference call tod
Show less
Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health Investments (CLOV): Revisiting Valuation After Recent Share Price Volatility and Turnaround Hopes [Yahoo! Finance]Yahoo! Finance
- Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare ConferenceGlobeNewswire
- Clover Health (CLOV): Assessing Valuation as 2026 GAAP Profitability Becomes the Next Potential Turning Point [Yahoo! Finance]Yahoo! Finance
- Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits [Seeking Alpha]Seeking Alpha
- Clover Health Investments (NASDAQ:CLOV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
CLOV
Earnings
- 11/4/25 - In-Line
CLOV
Analyst Actions
- 11/6/25 - Canaccord Genuity
CLOV
Sec Filings
- 12/18/25 - Form 4
- 12/18/25 - Form 144
- 12/16/25 - Form 4
- CLOV's page on the SEC website